1. Home
  2. Medical News
  3. Optometry

CooperVision MiSight 1 Day Officially Launches in China

08/15/2022
CooperVision MiSight 1 Day Officially Launches in China image

CooperVision and EssilorLuxottica have officially launched MiSight 1 day contact lenses in China, marking its availability in the world’s largest country for myopia management. It is the first product of any type that has an indication from the Chinese National Medical Products Administration (NMPA) for slowing the progression of axial length.[1]

EssilorLuxottica is the exclusive distributor of MiSight 1 day in China’s mainland. Representatives from both companies were joined by several domestic and international ophthalmology and optometry luminaries during a virtual ‘grand launch’ conference earlier this month.

“CooperVision is dedicated to pioneering, innovative, and life-changing eye care technologies. Backed by an international, 7-year clinical study, we are proud to launch this groundbreaking myopia management treatment for children and adolescents in China. In cooperation with EssilorLuxottica, China joins the family of more than 30 markets in which MiSight 1 day is being prescribed,” Juan Carlos Aragón, President of CooperVision Specialty EyeCare, said in a company news release. 

The overall prevalence of myopia among Chinese children and adolescents in 2018, 2019 and 2020 was 53.6%, 50.2%, and 52.7%, respectively. In 2020, the myopia rate for students in primary school, middle school, and high school reached 35.6%, 71.1%, and 80.5%. [2]

MiSight 1 day will be available in all major cities in China. 

References

1 MiSight is indicated for the correction of myopia for patients with non-diseased phakic eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 D to -4.00 D with ≤ 0.75 diopters of astigmatism. It has the dual focal design with alternative multiple rings, which allows part of the light passing through the optical zone to focus in front of the retina, forming myopic defocus with the expectation to slow the change of axial length of the patients. Fitting and evaluation of the product should be in medical institutions by ophthalmologists with an intermediate title or above and with regular monitoring. It must be used in strict accordance with the IFU requirements.

2 National Health Commission. 13 July 2021. Myopia survey conducted from September to December 2020, covering 8,604 schools across the country and screening a total of 2.477 million students. Retrieved from: http://www.nhc.gov.cn/xwzb/webcontroller.do?titleSeq=11389&gecstype=1

Register

We're glad to see you're enjoying Modern Optometry…
but how about a more personalized experience?

Register for free